Funded Startups in Valencia
The largest disclosed round in this Valencia-focused list is SetPoint Medical’s $115M (2025-08-11), which sits far above the next-largest disclosed amounts…
The largest disclosed round in this Valencia-focused list is SetPoint Medical’s $115M (2025-08-11), which sits far above the next-largest disclosed amounts: $110K is the smallest scale on the top end, while several materially larger rounds cluster under $100M (e.g., ARTHEx Biotech’s $41M on 2025-09-17, Nusano’s $115M on 2024-10-01, and Jeff’s $49M on 2023-02-03). At the small end, Colibid’s $440K (2024-09-19) is the lowest disclosed amount among the rows with disclosed figures.
Date-wise, rounds span 2022-01-24 (ClimateTrade) through 2025-11-17 (Voltrac), with a dense run in late 2024 to mid-2025: multiple rounds appear from 2025-01-28 (iPronics $21M; Quibim $50M) and 2025-02-18 (Imperia $11M), while several 2024 entries also concentrate around September–October 2024 (e.g., ARTHEx Biotech appears in 2025, but earlier biotech/health activity is visible via Nusano’s $115M on 2024-10-01 and Colibid’s $440K on 2024-09-19). Sector distribution is broad, but Biotechnology appears repeatedly in this slice (ARTHEx Biotech, SetPoint Medical, Valencia Technologies, Evolving Therapeutics, Avita Medical), and the dataset also shows frequent amount uncertainty: 10 of 50 rows are “undisclosed” and 12 of 50 are labeled “Series Unknown,” which shapes how much can be compared across stage and size. Geographically, most entries are listed as Valencia, Comunidad Valenciana, Spain; a smaller subgroup uses different state/city combinations with the Valencia label (e.g., Valencia, California for SetPoint Medical; Valencia, Pennsylvania for Gus Gear), which is worth treating separately when mapping pipeline coverage.
Most recent rounds
50 shownRelated listings
Frequently asked
What’s the biggest disclosed round in the Valencia list, and how does it compare to the rest of the disclosed amounts?
SetPoint Medical shows the largest disclosed amount at $115M on 2025-08-11; Nusano is also disclosed at $115M but on 2024-10-01. Outside those two $115M entries, the next-high disclosed amounts are materially lower (for example, ARTHEx Biotech at $41M on 2025-09-17 and Jeff at $49M on 2023-02-03).
Are the most active funding periods clustered in a narrow window, or spread evenly across years?
The rounds span 2022-01-24 through 2025-11-17, but the density increases around 2024-09 to 2025-02: for instance, Colibid ($440K) closes on 2024-09-19, Nusano ($115M) on 2024-10-01, and a tight pair lands on 2025-01-28 (iPronics $21M and Quibim $50M). Multiple additional rounds land in 2025 mid-year (e.g., SetPoint Medical $115M on 2025-08-11 and Laberit $12M on 2025-09-25).
Which sector repeats enough to form a cluster in this slice?
Biotechnology is the most consistently repeated sector: ARTHEx Biotech (Series B, $41M on 2025-09-17), SetPoint Medical (Series D, $115M on 2025-08-11), Valencia Technologies ($35M on 2025-02-20), Evolving Therapeutics (Angel, $100K on 2025-01-21), and Avita Medical ($40M on 2023-10-18) all appear as Biotechnology in the rows shown.
How much ambiguity in stage or disclosure limits comparisons, and where is it visible?
Amount disclosure is incomplete: 10 of the 50 rows are “undisclosed” (e.g., TrustWorks on 2025-08-26; BigBuy on 2025-06-17; Sepiia on 2023-07-13). Stage naming is also opaque: 12 of 50 are labeled “Series Unknown” (e.g., Therminer on 2024-10-16; FYLA on 2023-12-04; Tuvalum on 2022-11-07 is not, but multiple others are), which reduces like-for-like stage comparisons.
Are there geographic outliers due to different ‘Valencia’ locations rather than the same city/country?
Yes. While most rows list Valencia, Comunidad Valenciana, Spain (e.g., Voltrac on 2025-11-17; ARTHEx Biotech on 2025-09-17), several use other Valencia-linked locations: SetPoint Medical and Valencia Technologies list Valencia, California, United States (2025-08-11 and 2025-02-20), and Gus Gear lists Valencia, Pennsylvania, United States (Grant, $300K on 2022-01-26).
What are the smallest disclosed rounds, and do they come from a single segment or stage pattern?
The smallest disclosed amount is $100K for Evolving Therapeutics (Angel, 2025-01-21), with another low datapoint at $220K for Mas Leads (Pre-Seed, 2023-12-13). These low ends span different stages (Angel vs. Pre-Seed) and aren’t confined to a single sector in the disclosed rows (Evolving Therapeutics is Biotechnology, while Mas Leads is Artificial Intelligence).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.